{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:56:16Z","timestamp":1771026976454,"version":"3.50.1"},"reference-count":0,"publisher":"Stichting Nase","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rhin"],"abstract":"<jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP) often co-exists with asthma and non-steroidal anti-inflammatory drug-\nexacerbated respiratory disease (N-ERD), creating a more severe phenotype and an additional burden compared with CRSwNP disease alone (1-3). The relationship between these diseases in terms of shared immunological disbalance has been coined in the literature as \u2018global airway disease\u2019 or \u2018unified airway disease\u2019 and requires integrated treatment strategies (4-6). Our post hoc analysis of the Phase III randomised, double-blind, placebo-controlled, multicentre SYNAPSE study (GSK ID: 205687; NCT03085797 (7)) assessed the efficacy of mepolizumab, an anti-interleukin-5 monoclonal antibody, in simultaneously improving both CRSwNP and asthma outcomes versus placebo. By utilising a combined measure that accounts for quality of life, sinonasal symptoms and asthma control, we aimed to validate the potential of mepolizumab as an effective therapeutic option for global airway disease.<\/jats:p>","DOI":"10.4193\/rhin24.337","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:00:32Z","timestamp":1736348432000},"page":"0-0","source":"Crossref","is-referenced-by-count":3,"title":["Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma"],"prefix":"10.4193","volume":"0","author":[{"given":"J","family":"Mullol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Backer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Constantinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Egu\u00edluz-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Moure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Cuervo-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2708","published-online":{"date-parts":[[2024,12,1]]},"container-title":["Rhinology Journal"],"original-title":[],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:00:35Z","timestamp":1736348435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rhinologyjournal.com\/Abstract.php?id=3243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":0,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.4193\/rhin24.337","relation":{},"ISSN":["0300-0729"],"issn-type":[{"value":"0300-0729","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}